Skip to main content
Equibles
RXRX $3.70 +3.35%
RXRX logo
RXRX · Recursion Pharmaceuticals, Inc.
Track RXRX — free

Use RXRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RXRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.70 +0.12 (+3.35%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$1.98B
Shares
535.34M
Volume · Oct 23 19.08M Avg daily vol (3M) 21.75M
All webcasts

Earnings call · FY2022 Q4

Recursion Pharmaceuticals, Inc. (RXRX) Q4 2022 Earnings Call

Concluded Feb 27, 2023
Feb 27, 2023 0 turns
Period
FY2022 Q4
Runtime
—
Sources
2 artifacts
Revenue · derived Q4 $13.68M +439.9% YoY
Gross margin · derived Q4 20.7% -79.3 pp YoY
Net income · derived Q4 -$57.49M
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Feb 27, 2023 10-K report Filed Feb 27, 2023
Full-screen source Call document

RXRX alerts

Recursion Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →